GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yantai Dongcheng Biochemicals Co Ltd (SZSE:002675) » Definitions » Beneish M-Score

Yantai Dongcheng Biochemicals Co (SZSE:002675) Beneish M-Score : -2.30 (As of Apr. 17, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Yantai Dongcheng Biochemicals Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.3 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Yantai Dongcheng Biochemicals Co's Beneish M-Score or its related term are showing as below:

SZSE:002675' s Beneish M-Score Range Over the Past 10 Years
Min: -2.95   Med: -2.5   Max: -2.27
Current: -2.3

During the past 13 years, the highest Beneish M-Score of Yantai Dongcheng Biochemicals Co was -2.27. The lowest was -2.95. And the median was -2.50.


Yantai Dongcheng Biochemicals Co Beneish M-Score Historical Data

The historical data trend for Yantai Dongcheng Biochemicals Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yantai Dongcheng Biochemicals Co Beneish M-Score Chart

Yantai Dongcheng Biochemicals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.41 -2.95 -2.86 -2.57 -2.30

Yantai Dongcheng Biochemicals Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.57 -2.36 -2.29 -2.32 -2.30

Competitive Comparison of Yantai Dongcheng Biochemicals Co's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Yantai Dongcheng Biochemicals Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yantai Dongcheng Biochemicals Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yantai Dongcheng Biochemicals Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Yantai Dongcheng Biochemicals Co's Beneish M-Score falls into.


;
;

Yantai Dongcheng Biochemicals Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Yantai Dongcheng Biochemicals Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3503+0.528 * 0.9518+0.404 * 1.0102+0.892 * 0.8758+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9421+4.679 * -0.011966-0.327 * 0.8843
=-2.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was ¥949 Mil.
Revenue was 706.505 + 741.721 + 773.482 + 647.229 = ¥2,869 Mil.
Gross Profit was 367.523 + 350.643 + 350.794 + 283.448 = ¥1,352 Mil.
Total Current Assets was ¥2,568 Mil.
Total Assets was ¥8,635 Mil.
Property, Plant and Equipment(Net PPE) was ¥2,335 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥411 Mil.
Total Current Liabilities was ¥1,754 Mil.
Long-Term Debt & Capital Lease Obligation was ¥336 Mil.
Net Income was 16.958 + 55.078 + 47.462 + 64.328 = ¥184 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 102.204 + 202.733 + 147.532 + -165.319 = ¥287 Mil.
Total Receivables was ¥802 Mil.
Revenue was 690.304 + 800.333 + 934.51 + 850.5 = ¥3,276 Mil.
Gross Profit was 337.049 + 336.582 + 392.565 + 403.494 = ¥1,470 Mil.
Total Current Assets was ¥2,478 Mil.
Total Assets was ¥8,082 Mil.
Property, Plant and Equipment(Net PPE) was ¥2,147 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥498 Mil.
Total Current Liabilities was ¥1,952 Mil.
Long-Term Debt & Capital Lease Obligation was ¥260 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(948.724 / 2868.937) / (802.194 / 3275.647)
=0.330688 / 0.244896
=1.3503

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1469.69 / 3275.647) / (1352.408 / 2868.937)
=0.448672 / 0.471397
=0.9518

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2567.649 + 2334.898) / 8634.678) / (1 - (2477.686 + 2146.706) / 8082.354)
=0.432226 / 0.427841
=1.0102

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2868.937 / 3275.647
=0.8758

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 2146.706)) / (0 / (0 + 2334.898))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(411.174 / 2868.937) / (498.336 / 3275.647)
=0.143319 / 0.152134
=0.9421

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((335.741 + 1753.956) / 8634.678) / ((260.275 + 1951.726) / 8082.354)
=0.242012 / 0.273683
=0.8843

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(183.826 - 0 - 287.15) / 8634.678
=-0.011966

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Yantai Dongcheng Biochemicals Co has a M-score of -2.30 suggests that the company is unlikely to be a manipulator.


Yantai Dongcheng Biochemicals Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Yantai Dongcheng Biochemicals Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Yantai Dongcheng Biochemicals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 7 ChangBaishan Road, Yan Tai Development Zone, ShanDong, CHN, 264006
Yantai Dongcheng Biochemicals Co Ltd is a biochemical analytical profile index (API) manufacturers in China. In addition, the company also focuses on the development of finished preparation which covers the therapeutic area of cardiovascular, oncology, orthopedics, and anti-infection. Its product offering includes heparin sodium, chondroitin sulfate, marine collagen, hyaluronic acid, glucosamine, heparinoids, and cytochrome C. The company's API products have been exported to more than fifty countries and regions, including the United States of America, Germany, Austria, and Japan.
Executives
Xin Hong Bo Directors, executives
Luo Zhi Gang Executives
You Shou Yi Directors, executives
Lv Chun Xiang Supervisors
Sun Hong Tao Supervisors
Yi Qiong Executives
Yang Zhen Qiu Executives
Bai Xing Hua Directors, executives
Song Zhao Long Supervisors
Wen Lei Director
Zhu Chun Ping Executives
Qi Dong Qi Directors, executives
Liu Xiao Jie Securities Affairs Representative
Wang En Zheng Independent director
Shi Tao Supervisors

Yantai Dongcheng Biochemicals Co Headlines

No Headlines